Individual spermatozoa from the father of two affected infants with osteogenesis imperfecta were separated by dilution and micromanipulation. A segment of the type I collagen gene containing the mutant region was amplified by nested polymerase chain reaction and sequenced. Among 40 individual spermatozoa, 15 specimens were identified as mutants with a substitution of guanine 3208 to adenine (glycine 882 to serine) while 18 and seven specimens were of the wild and mixed types respectively. Through this study, we have established a molecular procedure that can be considered as prerequisite for preimplantation diagnosis of genetic disorders with a single point mutation.
Introduction
Osteogenesis imperfecta is a dominant disease, characterized by individual variability with early mortality among severely affected infants, chiefly related to respiratory failure (Silence et al, 1984) . The majority of severe cases represent a sporadic occurrence within separate families, presumably involving fresh gene mutations, for which the parents need to be little concerned about recurrence. Affected siblings, however, have been reported, indicating that this is due to the presence of mosaicism and a mutant gene in one parent (Conn et al, 1990; Constantinou et al, 1993) . Here, we analysed a family with recurrent lethal osteogenesis imperfecta in which a mutation of Gly 862 to Ser in an a 1 chain of the type I collagen gene (COL1A1), the product of a gene on chromosome 17, was present in the affected children, and demonstrated the existence of the same mutation in their father in a mosaic form. Genetic diseases can now be identified in an embryo before it is implanted into the uterus. Such preimplantation diagnosis requires the performance of genetic analysis using only a small number of cells derived from the pre-embryo stage (Delhanty, 1994) .
In this study, we amplified DNA sequences containing the mutated segment of COL1A1 in a single spermatozoon from a father with germ-line mosaicism and have obtained experimental evidence demonstrating a point mutation. This procedure should enable reliable preimplantation diagnosis to be performed for a wide variety of genetic disorders.
Materials and methods

Patients and family
A 36 year old woman, whose first pregnancy resulted in a male infant with osteogenesis imperfecta, presented at the 1 Oth week of gestation.
Multiple fractures had been noted in the previous child, and he died of respiratory failure at 3 years of age. With the second child, prenatal ultrasonography revealed shortening and fracture of the femur in the last trimester of pregnancy, indicating a recurrence (Thompson, 1993) , which was confirmed after birth.
Skin fibroblasts of both infants were analysed for mutations of COL1A1 and a single base substitution leading to the conversion of glycine 862 to serine was demonstrated. The same mutation of COL 1A1 was also detected in cells derived from the father. Moreover, mosaicism of COL1A1 gene could be demonstrated in the father since different frequencies of mutant cell populations were observed (Namikawa et al, 1995) .
Single sperm preparation
A semen sample (~3 ml) donated from the father was washed three times with phosphate-buffer saline (PBS) and diluted to a concentration'of 200 cells/ml. Single spermatozoa were isolated under an inverted microscope (Nikon, Tokyo, Japan) equipped with a micromanipulator (Narishige, Tokyo, Japan). The micropipettes used for separating single spermatozoa in this study were made from glass microcapillaries (Drummond Scientific, Broomall, PA, USA) with an average internal diameter of 20 |im. The isolated single spermatozoa were individually washed three times, transferred separately to a 5 ul drop of sterile water and placed in an Eppendorf tube under the microscope. Tubes containing a single spermatozoon as well as the last-wash medium were stored at -80°C until use. In a series of experiments, we applied genotyping to 100 individual sperm preparations. To lyse the cells for DNA analysis, the samples were thawed, heated at 95°C for 20 min in a DNA Thermal Cycler (PerkinElmer Cetus, Norwalk, CT, USA) and sedimented by centrifugation prior to amplification. Last-wash medium and genomic DNA samples were used as negative and positive controls respectively in all amplification experiments. Because the negative controls do not contain any added DNA, no amplification signal should be seen.
Polymerase chain reaction and sequencing
Nested polymerase chain reaction (PCR) was carried out to amplify, from a single spermatozoon, the portion of the cDNA gene segment 
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Mutant I>|H" \Vil(l'l\|)r of COLlAl exon 44 containing the mutation site The PCR primers used are listed in Table I (see also Figure I for the location). For the first PCR, the sperm DNA was amplified in a PCR buffer [50 mM KCI. 10 mM Tns-HCl (pH 8.3). 2 mM MgCk 0.1 mg/ml gelatin] containing I uM of each pnmer, 200 |iM of each dNTP and Taq DNA polymerase (Perkin-Elmer Cetus. Norwalk CT. USA). PCR was carried out for 30 cycles (denaturation at 94°C for 45 s, annealing at 60°C for 45 s and extension at 72°C for 5 mm) in a DNA thermal cycler. For the second PCR. a sample (1 u.1) of the first PCR product was used as a template and the reactions were similarly performed with the second (internal) PCR pnmer set After two rounds of amplification, the PCR products were analysed by 2% agarose gel electrophoresis. The amplified 174 bp DNA fragment was separated by filtration using Micron 100 with an exclusion molecular weight of 100 kDa (Amicon. MA. USA). Nucleotide sequencing reactions were performed by the dideoxy termination method using a DNA sequencing kit (Sequi Therm Cycle sequencing Kit; Epicentre Technologies. NE, USA) with a dye-labelled sequence primer and an automatic DNA sequencer (Model 4000. Ll-COR. Lincoln. NE. USA)
Results
Amplification of the target sequence from a single sperm cell preparation Spermatozoa samples (n = 100) were isolated using the micromanipulator and amplified by nested PCR. During isola- tion, spermatozoa often attached to the wall of the micropipette and burst, so we could not completely exclude the possibility that more than one spermatozoon was present in each preparation. All amplified products plus 10 negative controls were analysed by agarose electrophoresis. None of the controls demonstrated DNA amplification. In 88 samples, the 174 bp DNA fragment was detected, but 12 samples had either a weak or no such band.
Sequencing of the amplified products
Among the amplified DNA products. 40 samples were randomly selected and the DNA sequences automatically determined (Figure 2) . A total of 15 samples (37.5%) were shown to contain a guanine substitution by adenine at nucleotide position 3208 (thus conversion of Gly X62 to Ser). However, the sequences of 18 (45.0%) and seven samples (17.5%) were either of the wild type or mixed type (containing both wild type and a G to A substitution at position 3208) respectively (Table II) .
Discussion
Mutations in the genes coding for the al and cc2 chains of type I collagen (COLlAl and COL1A2) have been found in many patients with osteogenesis imperfecta (Byers et al., 1991; Kuivaniemi et al., 1991) . In this study we examined a family with two consecutive affected siblings bom from phenotypically normal parents. The cause of the recurrence could be ascribed to somatic cell mosaicism accompanied by germinal mosaicism in the father.
Here we determined the genotype of a single spermatozoon by nested PCR followed by direct sequencing and could thereby evaluate the mutant allele frequency. In our previous report regarding the same family, we documented that allelespecific colony hybridization revealed the mutant allele in -43% of the father's spermatozoa (Namikawa et al., 1995) , indicating that 86% of his spermatogonia are heterozygous for this mutant allele. Analysis of the genotype of a single spermatozoon at the DNA level should provide more precise information. We therefore attempted to determine directly the frequency of the mutant allele in the father's spermatozoa. The efficiency of amplification of the target sequence from a single spermatozoon was 88%. Of the analyzed spermatozoa, 82.5% carried one allele: 37.5% contained the mutant and 45% the normal allele. The remainder (17.5%) carried both alleles, indicating that two or more spermatozoa or contaminating diploid DNA sequences were present. This latter could be a source of inaccuracy under certain circumstances, requiring DNA 'fingerprinting' for reliable detection (Findlay et al, 1995a) . The possibility of allelic drop-out or preferential amplification should also taken into account (Findlay et al, 1995b) . Our data for single sperm genotype are consistent with those of the previous investigation. This figure is far higher than that of autosomal recessive disease (25%) and is close to the 50% that would indicate a dominant disease, considering the mosaicism.
The analysis of haplotype sperm at the DNA level is a unique tool for the study of genetic diseases, especially in cases of autosomal dominance, as well as general analysis of DNA sequences (Li et al, 1988) . One significant advantage of this approach is that the recurrence risk can be better explained to the parents. Such parents often require prenatal diagnosis involving chorionic villus sampling or amniocentesis with a view to terminating any affected fetuses. Parents at high risk, such as those described here, are likely to develop considerable psychological trauma. However, when single cell analysis of genetic disease is available, it becomes possible to diagnose genetic disease even before initiation of pregnancy, thus obviating unnecessary need for artificial abortion.
This preimplantation diagnosis involves in-vitro fertilization (TVF) to obtain a number of embryos, removal of a single or a few cells from the 4-to 8-cell embryo by micromanipulation, and genetic analysis to determine the presence or absence of a specific genetic defect. While genetic mosaicism has been reported to exist between individual blastomeres in an embryo (Munne" et al, 1993; Jamieson et al, 1994) pointing to benefits of using single cells, DNA amplification efficiency may be improved when two or more embryonic cells are processed (Pickering et al, 1995) . The first clinical application of preimplantation diagnosis was performed to select a female embryo, for which pre-embryos were at risk of X-linked disease, including Duchenne muscular dystrophy and LeschNyhan disease (Handyside et al, 1990) . Another successful example of preimplantation diagnosis was that applied to couples at risk of cystic fibrosis. The first unaffected child born following embryo selection by DNA analysis was reported in 1992 (Handyside et al, 1992) . So far, preimplantation diagnosis of single gene defects has also been successful for Tay-Sachs disease, Lesch-Nyhan disease, Duchenne muscular dystrophy, haemophilia A, al-antitrypsin deficiency, and retinitis pigmentosa (Monk, 1993) . Delhanty has recently reviewed 32 pregnancies that were established following preimplantation diagnosis with 29 babies bom and found no evidence of adverse effects on development (Delhanty, 1994) .
In the present study, we have expanded the notion of preimplantation diagnosis to an autosomal dominant disease, osteogenesis imperfecta. It should be noted that failed PCR amplification was observed for 12% of single sperm preparations and 17.5% of PCR products showed mixed type, indicating technical limitations to single cell genetic diagnosis of this disease. In fact, several misdiagnoses have been reported following preimplantation embryo genetic analyses. These are considered to be due to technical difficulties involved in embryo biopsy, including contamination with maternal cells and failed PCR amplification (Strom and Rechitsky, 1991) . The probability of error in preimplantation diagnosis has been estimated as being as high as 1.8% for autosomal recessive genes, 15% for autosomal dominant genes, and 7.4% for Xlinked recessive genes (Navidi and Ahnheim, 1991) . However, taken together, the efficiency and accuracy of our procedure were high enough to justify preimplantation diagnosis for osteogenesis imperfecta in practice. The entire diagnostic procedure can be performed within a day, so that embryos could be transferred to the mother on the day following the biopsy of a single blastomere from the embryo. Application of blastomere typing to select an affected embryo should considerably contribute to terminating transmission of affected alleles, although sources of error must clearly be further investigated.
